Publicaciones en colaboración con investigadores/as de Universidade Federal do Paraná (90)

2024

  1. Variability in Drug Procurement within Group 1B of the Pharmaceutical Specialized Scheme in Brazil

    Ciencia e Saude Coletiva, Vol. 29, Núm. 1

2023

  1. Chemical Constituents, Anticancer and Anti-Proliferative Potential of Limonium Species: A Systematic Review

    Pharmaceuticals, Vol. 16, Núm. 2

  2. Correction: Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies (DARU Journal of Pharmaceutical Sciences, (2023), 31, 1, (51-68), 10.1007/s40199-023-00461-3)

    DARU, Journal of Pharmaceutical Sciences

  3. Efficacy and safety of pharmacological interventions for managing sickle cell disease in children and adolescents: protocol for a systematic review with network meta-analysis

    BMJ open, Vol. 13, Núm. 2, pp. e064872

  4. Flavonoid as possible therapeutic targets against COVID-19: a scoping review of in silico studies

    DARU, Journal of Pharmaceutical Sciences, Vol. 31, Núm. 1, pp. 51-68

2022

  1. Best practices when conducting and reporting a meta-analysis

    Contemporary Research Methods in Pharmacy and Health Services (Elsevier), pp. 85-101

  2. Bioactive compounds as potential angiotensin-converting enzyme II inhibitors against COVID-19: a scoping review

    Inflammation Research, Vol. 71, Núm. 12, pp. 1489-1500

  3. Confusing terminology used in the abbreviation of pharmacy journal names

    Research in Social and Administrative Pharmacy, Vol. 18, Núm. 8, pp. 3463-3465

  4. Efficacy and safety of daily treatments for drug-susceptible pulmonary tuberculosis: a systematic review and network meta-analysis

    Journal of Pharmacy and Pharmacology, Vol. 74, Núm. 6, pp. 905-917

  5. Mapping community pharmacy services in Brazil: a scoping review

    Brazilian Journal of Pharmaceutical Sciences, Vol. 58

  6. Methodological quality and risk of bias of meta-analyses of pharmacy services: A systematic review

    Research in Social and Administrative Pharmacy, Vol. 18, Núm. 3, pp. 2403-2409

  7. Methodological standards for conducting and reporting meta-analyses: Ensuring the replicability of meta-analyses of pharmacist-led medication review

    Research in Social and Administrative Pharmacy, Vol. 18, Núm. 2, pp. 2259-2268

  8. Pharmacovigilance: an evaluation on the practice of pharmacists acting in pharmacies and drugstores

    Brazilian Journal of Pharmaceutical Sciences, Vol. 58

  9. Systematic review with network meta-analysis on the treatments for latent tuberculosis infection in children and adolescents

    Journal of Infection and Chemotherapy, Vol. 28, Núm. 12, pp. 1645-1653

  10. The naturally-derived alkaloids as a potential treatment for COVID-19: A scoping review

    Phytotherapy Research, Vol. 36, Núm. 7, pp. 2686-2709

  11. Use of ‘Pharmaceutical services’ Medical Subject Headings (MeSH) in articles assessing pharmacists' interventions

    Exploratory Research in Clinical and Social Pharmacy, Vol. 7

2021

  1. Chemotherapy Treatments for Burkitt Lymphoma: Systematic Review of Interventional Studies

    Clinical Lymphoma, Myeloma and Leukemia, Vol. 21, Núm. 8, pp. 514-525

  2. Efficacy and safety of oral phosphodiesterase 5 inhibitors for erectile dysfunction: a network meta-analysis and multicriteria decision analysis

    World Journal of Urology, Vol. 39, Núm. 3, pp. 953-962

  3. Implications of a defined daily dose fixed database for drug utilization research studies: The case of statins in Portugal

    British Journal of Clinical Pharmacology, Vol. 87, Núm. 9, pp. 3542-3549

  4. Lag times in the publication of network meta-analyses: A survey

    BMJ Open, Vol. 11, Núm. 9